Skip to Main Content
Accessibility Overview
webinar register page
Webinar Registration
Facebook
Twitter
LinkedIn
Microsoft (Outlook)
Topic
Lupus Health Conference_April 8, 2023
Time
Apr 8, 2023 11:00 AM in
Pacific Time (US and Canada)
*
Required information
Loading
Register
Speakers
Dr. Elizabeth Clayton
Dr.
Elizabeth S. Clayton, MD is a rheumatologist and managing partner of Rheumatology Associates of the DelMarVA. Elizabeth S. Clayton, MD, is a Rheumatologist with University of Maryland Shore Regional Health - Dorchester/Easton, University of Maryland Medical System in Easton, Maryland. Dr. Clayton received her medical degree from University of Maryland School of Medicine in Baltimore, Maryland, and completed her residency at University of Maryland Medical Center, also in Baltimore. She served her fellowship at the University of Maryland School of Medicine. With board certifications in rheumatology and internal medicine, her clinical expertise is in general rheumatology. She is a fellow of American College of Rheumatology and has publications in Current Osteoporosis Reports, Current Opinion in Rheumatology, and British Journal of Surgery.
Dr. C. Michael Neuwelt
Dr
Dr. Neuwelt has been challenged and fascinated by SLE since 1973 during his third year of medical school. This challenge and interest has persisted throughout his 43 years in clinical private practice which began in 1979. His original publications involve an observational series and case reports of severe Neuropsychiatric Lupus (NPSLE), including progressive multifocal leukoencephalopathy mimicking NPSLE, and three treatment studies of Severe NPSLE with Cyclophosphamide, Rituximab, and plasmapheresis. Dr. Neuwelt also participated in subcutaneous Belimumab trials and ongoing Belimumab plus standard-of-care treatment in Lupus Nephritis. In 2018 a trial began of Belimumab plus Rituximab with the primary endpoint being relative remission in SLE. In January of 2014 Dr. Neuwelt became the first Purple Ribbon Honoree for Outstanding Commitment to Lupus Treatment and Research from the Lupus Foundation of Northern California.
×
Share via Email
All fields are required
Your Information
Send to
Message preview
Hi there, You are invited to a Zoom webinar. When: Apr 8, 2023 11:00 AM Pacific Time (US and Canada) Topic: Lupus Health Conference_April 8, 2023 Register in advance for this webinar: https://us02web.zoom.us/webinar/register/WN_0yz1HIRAT5C7bkMBbDpIfw After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Dr. Elizabeth Clayton (Dr. ) Elizabeth S. Clayton, MD is a rheumatologist and managing partner of Rheumatology Associates of the DelMarVA. Elizabeth S. Clayton, MD, is a Rheumatologist with University of Maryland Shore Regional Health - Dorchester/Easton, University of Maryland Medical System in Easton, Maryland. Dr. Clayton received her medical degree from University of Maryland School of Medicine in Baltimore, Maryland, and completed her residency at University of Maryland Medical Center, also in Baltimore. She served her fellowship at the University of Maryland School of Medicine. With board certifications in rheumatology and internal medicine, her clinical expertise is in general rheumatology. She is a fellow of American College of Rheumatology and has publications in Current Osteoporosis Reports, Current Opinion in Rheumatology, and British Journal of Surgery. Dr. C. Michael Neuwelt (Dr ) Dr. Neuwelt has been challenged and fascinated by SLE since 1973 during his third year of medical school. This challenge and interest has persisted throughout his 43 years in clinical private practice which began in 1979. His original publications involve an observational series and case reports of severe Neuropsychiatric Lupus (NPSLE), including progressive multifocal leukoencephalopathy mimicking NPSLE, and three treatment studies of Severe NPSLE with Cyclophosphamide, Rituximab, and plasmapheresis. Dr. Neuwelt also participated in subcutaneous Belimumab trials and ongoing Belimumab plus standard-of-care treatment in Lupus Nephritis. In 2018 a trial began of Belimumab plus Rituximab with the primary endpoint being relative remission in SLE. In January of 2014 Dr. Neuwelt became the first Purple Ribbon Honoree for Outstanding Commitment to Lupus Treatment and Research from the Lupus Foundation of Northern California.
×
Switch Time Zone
Time Zone:
(GMT-11:00) Midway Island, Samoa
(GMT-11:00) Pago Pago
(GMT-10:00) Hawaii
(GMT-8:00) Alaska
(GMT-8:00) Juneau
(GMT-7:00) Vancouver
(GMT-7:00) Pacific Time (US and Canada)
(GMT-7:00) Tijuana
(GMT-7:00) Arizona
(GMT-7:00) Mazatlan
(GMT-7:00) Yukon
(GMT-6:00) Edmonton
(GMT-6:00) Mountain Time (US and Canada)
(GMT-6:00) Saskatchewan
(GMT-6:00) Mexico City
(GMT-6:00) Guatemala
(GMT-6:00) El Salvador
(GMT-6:00) Managua
(GMT-6:00) Costa Rica
(GMT-6:00) Tegucigalpa
(GMT-6:00) Chihuahua
(GMT-6:00) Monterrey
(GMT-5:00) Winnipeg
(GMT-5:00) Central Time (US and Canada)
(GMT-5:00) Panama
(GMT-5:00) Bogota
(GMT-5:00) Lima
(GMT-5:00) Acre
(GMT-4:00) Montreal
(GMT-4:00) Eastern Time (US and Canada)
(GMT-4:00) Indiana (East)
(GMT-4:00) Puerto Rico
(GMT-4:00) Caracas
(GMT-4:00) La Paz
(GMT-4:00) Guyana
(GMT-3:00) Halifax
(GMT-3:00) Santiago
(GMT-3:00) Montevideo
(GMT-3:00) Recife
(GMT-3:00) Buenos Aires, Georgetown
(GMT-3:00) Greenland
(GMT-3:00) Sao Paulo
(GMT-3:00) Atlantic Time (Canada)
(GMT-2:30) Newfoundland and Labrador
(GMT-2:00) Fernando de Noronha
(GMT-1:00) Azores
(GMT-1:00) Cape Verde Islands
(GMT+0:00) Universal Time UTC
(GMT+0:00) Greenwich Mean Time
(GMT+0:00) Reykjavik
(GMT+0:00) Dublin
(GMT+0:00) London
(GMT+0:00) Lisbon
(GMT+0:00) Casablanca
(GMT+0:00) Nouakchott
(GMT+1:00) Belgrade, Bratislava, Ljubljana
(GMT+1:00) Sarajevo, Skopje, Zagreb
(GMT+1:00) Oslo
(GMT+1:00) Copenhagen
(GMT+1:00) Brussels
(GMT+1:00) Amsterdam, Berlin, Rome, Stockholm, Vienna
(GMT+1:00) Amsterdam
(GMT+1:00) Rome
(GMT+1:00) Stockholm
(GMT+1:00) Vienna
(GMT+1:00) Luxembourg
(GMT+1:00) Paris
(GMT+1:00) Zurich
(GMT+1:00) Madrid
(GMT+1:00) West Central Africa
(GMT+1:00) Algiers
(GMT+1:00) Tunis
(GMT+1:00) Warsaw
(GMT+1:00) Prague Bratislava
(GMT+1:00) Budapest
(GMT+2:00) Helsinki
(GMT+2:00) Harare, Pretoria
(GMT+2:00) Sofia
(GMT+2:00) Athens
(GMT+2:00) Bucharest
(GMT+2:00) Nicosia
(GMT+2:00) Beirut
(GMT+2:00) Jerusalem
(GMT+2:00) Tripoli
(GMT+2:00) Cairo
(GMT+2:00) Johannesburg
(GMT+2:00) Khartoum
(GMT+2:00) Kyiv
(GMT+2:00) Chisinau
(GMT+3:00) Nairobi
(GMT+3:00) Istanbul
(GMT+3:00) Damascus
(GMT+3:00) Amman
(GMT+3:00) Moscow
(GMT+3:00) Baghdad
(GMT+3:00) Kuwait
(GMT+3:00) Riyadh
(GMT+3:00) Bahrain
(GMT+3:00) Qatar
(GMT+3:00) Aden
(GMT+3:00) Djibouti
(GMT+3:00) Mogadishu
(GMT+3:00) Minsk
(GMT+3:30) Tehran
(GMT+4:00) Dubai
(GMT+4:00) Muscat
(GMT+4:00) Baku, Tbilisi, Yerevan
(GMT+4:30) Kabul
(GMT+5:00) Yekaterinburg
(GMT+5:00) Islamabad, Karachi, Tashkent
(GMT+5:30) India
(GMT+5:30) Mumbai, Kolkata, New Delhi
(GMT+5:30) Colombo
(GMT+5:45) Kathmandu
(GMT+6:00) Almaty
(GMT+6:00) Dacca
(GMT+6:00) Astana, Dhaka
(GMT+6:30) Rangoon
(GMT+7:00) Novosibirsk
(GMT+7:00) Krasnoyarsk
(GMT+7:00) Bangkok
(GMT+7:00) Vietnam
(GMT+7:00) Jakarta
(GMT+8:00) Irkutsk, Ulaanbaatar
(GMT+8:00) Beijing, Shanghai
(GMT+8:00) Hong Kong SAR
(GMT+8:00) Taipei
(GMT+8:00) Kuala Lumpur
(GMT+8:00) Singapore
(GMT+8:00) Perth
(GMT+9:00) Yakutsk
(GMT+9:00) Seoul
(GMT+9:00) Osaka, Sapporo, Tokyo
(GMT+9:30) Darwin
(GMT+10:00) Vladivostok
(GMT+10:00) Guam, Port Moresby
(GMT+10:00) Brisbane
(GMT+10:30) Adelaide
(GMT+11:00) Canberra, Melbourne, Sydney
(GMT+11:00) Hobart
(GMT+11:00) Magadan
(GMT+11:00) Solomon Islands
(GMT+11:00) New Caledonia
(GMT+11:00) Lord Howe IsIand
(GMT+12:00) Kamchatka
(GMT+12:00) Fiji Islands, Marshall Islands
(GMT+13:00) Auckland, Wellington
(GMT+13:00) Independent State of Samoa
×
Continue to PayPal
Click to Continue
×
×
Upcoming Meetings
Would you like to start this meeting?
Would you like to start one of these meetings?
View more...